Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rigetti CEO Chad Rigetti Relinquishes Position To Focus On Product & Tech Development

Rigetti Computing, Inc (NASDAQ:RGTI), a full-stack quantum computing company, announced that its founder, Dr. Chad Rigetti, will transition from…
byAnusuya Lahiri
October 31, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Rigetti Computing, Inc (NASDAQ:RGTI), a full-stack quantum computing company, announced that its founder, Dr. Chad Rigetti, will transition from his position as President and CEO to focus on advancing its products and technology. 
  • As part of this next growth phase, Rigetti will conduct a CEO search for Dr. Rigetti’s successor.
  • The company was founded in 2013 by Chad Rigetti and now employs more than 190 people with offices in the U.S., U.K. and Australia.
  • Also Read: Rigetti Announces New Partnerships, Provides Business Updates at Inaugural Investor Day
  • Dr. Rigetti will continue to serve in his current role until a successor is identified and assumes the position.
  • Rigetti will release the third quarter 2022 results on November 14, 2022, after the market close. 
  • Price Action: RGTI shares traded higher by 4.31% at $2.20 on the last check Monday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Results From SURMOUNT-4 Published In JAMA Showed Zepbound Met The Primary Endpoint Of Mean Percent Change In Body Weight, And All Key Secondary Endpoints For Both Estimands, Compared To Placebo 52 Weeks After Randomization

By Benzinga Newsdesk
December 11, 12:04 PM
People who were randomized to placebo following the lead-in period experienced mean weight regain of 14.8% at 88 weeks, indicating Zepbound led to sustained weight loss compared to placeboFull results from the SURMOUNT-4

LLY